Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Milestone Scientific (NY: MLSS )

0.8089 -0.0051 (-0.63%)
Official Closing Price Updated: 8:00 PM EST, Nov 4, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Milestone Scientific

< Previous 1 2 Next >
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
MLSS Stock Earnings: Milestone Scientific Misses Revenue for Q2 2024
MLSS stock results show that Milestone Scientific missed on revenue for the second quarter of 2024. 
Via InvestorPlace
Why Comcast Shares Are Trading Lower By 6%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Recap: Milestone Scientific Q1 Earnings
Via Benzinga
Earnings Preview For Milestone Scientific
Via Benzinga
Milestone Scientific's Return On Capital Employed Overview
Via Benzinga
EXCLUSIVE: Milestone Scientific Announces Medicare Price Assignment For CompuFlo Epidural System For Back Pain Covering Additional US States
Milestone Scientific announced Novitas Solutions, has granted Medicare Part B Physician payment rate for the CompuFlo Epidural System under AMA's Category III CPT code 0777T. This impacts Medicare... 
Via Benzinga
EXCLUSIVE: Milestone Scientific Announces Favorable Medicare Pricing For CompuFlo Epidural System For Back Pain Covering Florida
FCSO grants favorable Medicare Part B price for Milestone Scientific's CompuFlo Epidural System in Florida, using CPT code 0777T. Milestone's innovative system reduces pain and improves accuracy in... 
Via Benzinga
MLSS Stock Earnings: Milestone Scientific Reported Results for Q1 2024
Milestone Scientific just reported results for the first quarter of 2024. 
Via InvestorPlace
MLSS Stock Earnings: Milestone Scientific Misses Revenue for Q4 2023
MLSS stock results show that Milestone Scientific missed on revenue for the fourth quarter of 2023. 
Via InvestorPlace
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Earnings Scheduled For April 1, 2024
Companies Reporting Before The Bell • Mach Natural Resources (NYSE:MNR) is projected to report quarterly earnings at $0.92 per share on revenue of $213.43 million. 
Via Benzinga
Oracle, Casey's General Stores And 3 Stocks To Watch Heading Into Monday
With U.S. stock futures trading mixed this morning on Monday, some of the stocks that may grab investor focus today are as follows: 
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
Baidu To Rally Around 31%? Here Are 10 Other Analyst Forecasts For Tuesday
Keybanc boosted the price target for Howmet Aerospace Inc. (NYSE: HWM) from $47 to $50. Keybanc analyst Philip Gibbs maintained an Overweight rating. Howmet Aerospace shares fell 0.1% to close at... 
Via Benzinga
10 Best Performing Penny Stocks In The Healthcare Sector
As with any other sector, not all healthcare penny stocks encounter success. In fact, most don’t do that well. Yet those that win often earn massive returns for investors. Here's a look at the 10 best... 
Via Talk Markets
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
It's time to start the day with another breakdown of the biggest pre-market stock movers traders need to know about on Wednesday! 
Via InvestorPlace
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Why Catalyst Biosciences Shares Are Trading Higher By 105%; Here Are 20 Stocks Moving Premarket
Gainers Catalyst Biosciences Inc (NASDAQ: CBIO) rose 105% to $0.49 in pre-market trading. South Korea's GC Biopharma said it has signed an asset purchase agreement with Catalyst Biosciences to acquire... 
Via Benzinga
Why Bellerophon Therapeutics Shares Are Trading Higher By 24%, Here Are 44 Stocks Moving In Tuesday's Mid-Day Session
Gainers 
Via Benzinga
Why Smith Micro Software Shares Are Trading Lower By Over 46%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Gainers Lucira Health, Inc. (NASDAQ: LHDX) jumped 354% to $0.6369 after the company announced FDA authorization for its at-home combination COVID-19 & flu test. 
Via Benzinga
Milestone Scientific's Return On Capital Employed Insights
Benzinga Pro data, Milestone Scientific (AMEX:MLSS) reported Q2 sales of $1.65 million. Earnings fell to a loss of $2.88 million, resulting in a 50.13% decrease from last quarter. 
Via Benzinga
Milestone Scientific: Q1 Earnings Insights
Milestone Scientific (AMEX:MLSS) reported its Q1 earnings results on Tuesday, May 17, 2022 at 07:00 AM. Here's what investors need to know about the announcement. Earnings Milestone Scientific reported... 
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
  OnFriday, 143 stocks hit new 52-week lows. 
Via Benzinga
Earnings Scheduled For November 15, 2022
Companies Reporting Before The Bell • Alkaline Water Co (NASDAQ:WTER) is likely to report quarterly loss at $0.05 per share on revenue of $18.31 million. 
Via Benzinga
Earnings Scheduled For May 17, 2022
Companies Reporting Before The Bell • On Holding (NYSE:ONON) is likely to report earnings for its first quarter. 
Via Benzinga
Why Senti Biosciences Shares Jumped Over 50%; Here Are 79 Biggest Movers From Yesterday
Gainers Senti Biosciences, Inc. (NASDAQ: SNTI) shares climbed 50.7% to close at $2.11 on Thursday after B of A Securities initiated coverage on the stock with a Buy rating and $7 price target. 
Via Benzinga
Why NLS Pharmaceutics Shares Dipped Over 23%; Here Are 67 Biggest Movers From Yesterday
Gainers 
Via Benzinga
A Preview Of Milestone Scientific's Earnings
Milestone Scientific (AMEX:MLSS) is set to give its latest quarterly earnings report on Tuesday, 2022-05-17. Here's what investors need to know before the announcement. Analysts estimate that Milestone... 
Via Benzinga
< Previous 1 2 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.